In conclusion, alterations in TGR5 expression in colon cancer may impact tumor cell proliferation, survival, immune regulation, and metabolism through various mechanisms, indicating its potential as a therapeutic target (Table 1). This evidence concerns the gene GPBAR1 and malignant colon neoplasm.